Xeroderma Pigmentosum
|
0.030 |
Biomarker
|
disease |
BEFREE |
Addition of T4 endonuclease V, which is reported to complement defects of XP cells, stimulated DNA repair synthesis by the 293 cell extract, and also complemented the defects of all XP cell extracts.
|
8386177 |
1993 |
Xeroderma Pigmentosum
|
0.030 |
Biomarker
|
disease |
BEFREE |
When this endonuclease V was microinjected into the cytoplasm of xeroderma pigmentosum (XP) cells of complementation group A, B, C, D, F, G or H, unscheduled DNA synthesis (UDS) above the residual level was detected in all the cells at a dose of about 10(3) molecules following UV irradiation.
|
2918866 |
1989 |
Xeroderma Pigmentosum
|
0.030 |
Biomarker
|
disease |
BEFREE |
The UV-induced unscheduled DNA synthesis (UDS) in cultured human fibroblasts of repair-deficient xeroderma pigmentosum complementation groups A and C was assayed after injection of identical activities of either Uvr excinuclease (UvrA, B, C and D) from Escherichia coli or endonuclease V from phage T4.
|
3014326 |
1986 |
Diabetes Insipidus
|
0.010 |
Biomarker
|
disease |
BEFREE |
We also subjected primers containing 3' penultimate deoxyinosine (dI) lesions, which mimic endonuclease V nicked repair intermediates, to pol I repair assay.
|
29223016 |
2018 |
Bipolar Disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
NPTX1 was significantly associated with BD (p = 0.004), while ENDOV was significantly associated with SZ (p = 0.0075) after Bonferroni correction.
|
25053281 |
2015 |
Schizophrenia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
NPTX1 was significantly associated with BD (p = 0.004), while ENDOV was significantly associated with SZ (p = 0.0075) after Bonferroni correction.
|
25053281 |
2015 |
Malignant neoplasm of skin
|
0.010 |
Biomarker
|
disease |
BEFREE |
In a clinical study of patients with XP, T4 endonuclease V (T4N5) liposome lotion applied for one year reduced the rates of actinic keratosis (AK) and skin cancer compared with placebo.
|
15603216 |
2004 |
Actinic keratosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
In a clinical study of patients with XP, T4 endonuclease V (T4N5) liposome lotion applied for one year reduced the rates of actinic keratosis (AK) and skin cancer compared with placebo.
|
15603216 |
2004 |
Colonic Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
EndoV/Ligase mutation scanning combined with PCR/LDR/Universal array proved superior to automated DNA sequencing for detecting p53 mutations in colon tumors.
|
11896624 |
2002 |
Precancerous Conditions
|
0.010 |
Biomarker
|
group |
BEFREE |
The use of T4 endonuclease V was of clinical efficacy in protecting patients with a nucleotide excision repair defect from premalignant and malignant skin lesions.
|
11809366 |
2001 |
Skin lesion
|
0.010 |
Biomarker
|
group |
BEFREE |
The use of T4 endonuclease V was of clinical efficacy in protecting patients with a nucleotide excision repair defect from premalignant and malignant skin lesions.
|
11809366 |
2001 |
Cockayne Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
The inability of denV to complement the NER defect in CS cells to normal levels implies an impaired ability to process denV incised lesions by the BER pathway, and suggests a role for the CS genes, particularly the CS-B gene, in BER.
|
9372849 |
1997 |